Korean Journal of Radiology

  • 제20권4호
  • /
  • Pages.542-557
  • /
  • 2019
  • /
  • 1229-6929(pISSN)
  • /
  • 2005-8330(eISSN)
대한영상의학회 (The Korean Society of Radiology)
권호 표지
DOI QR코드

DOI QR Code

Diagnosis and Surveillance of Incidental Pancreatic Cystic Lesions: 2017 Consensus Recommendations of the Korean Society of Abdominal Radiology

  • Eun Sun Lee (Department of Radiology, Chung-Ang University Hospital) ;
  • Jung Hoon Kim (Department of Radiology, Seoul National University Hospital) ;
  • Mi Hye Yu (Department of Radiology, Konkuk University Medical Center) ;
  • Seo-Youn Choi (Department of Radiology, Soonchunhyang University Bucheon Hospital) ;
  • Hyo-Jin Kang (Department of Radiology, Seoul National University Hospital) ;
  • Hyun Jeong Park (Department of Radiology, Chung-Ang University Hospital) ;
  • Yang Shin Park (Department of Radiology, Korea University Guro Hospital) ;
  • Jae Ho Byun (Department of Radiology, Asan Medical Center) ;
  • Sang Soo Shin (Department of Radiology, Chonnam National University Hospital) ;
  • Chang Hee Lee (Department of Radiology, Korea University Guro Hospital) ;
  • Korean Society of Abdominal Radiology (Korean Society of Abdominal Radiology)
  • 투고 : 2018.09.14
  • 심사 : 2018.11.30
  • 발행 : 2019.04.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

The occurrence of incidentally detected pancreatic cystic lesions (PCLs) is continuously increasing. Radiologic examinations including computed tomography and magnetic resonance imaging with magnetic resonance cholangiopancreatography have been widely used as the main diagnostic and surveillance methods for patients with incidental PCLs. Although most incidentally detected PCLs are considered benign, they have the potential to become malignant. Currently, we have several guidelines for the management of incidental PCLs. However, there is still debate over proper management, in terms of accurate diagnosis, optimal follow-up interval, and imaging tools. Because imaging studies play a crucial role in the management of incidental PCLs, the 2017 consensus recommendations of the Korean Society of Abdominal Radiology for the diagnosis and surveillance of incidental PCLs approved 11 out of 16 recommendations. Although several challenges remain in terms of optimization and standardization, these consensus recommendations might serve as useful tools to provide a more standardized approach and to optimize care of patients with incidental PCLs.

키워드

참고문헌

  1. Zhang XM, Mitchell DG, Dohke M, Holland GA, Parker L. Pancreatic cysts: depiction on single-shot fast spin-echo MR images. Radiology 2002;223:547-553  https://doi.org/10.1148/radiol.2232010815
  2. Lee KS, Sekhar A, Rofsky NM, Pedrosa I. Prevalence of incidental pancreatic cysts in the adult population on MR imaging. Am J Gastroenterol 2010;105:2079-2084  https://doi.org/10.1038/ajg.2010.122
  3. Kimura W, Nagai H, Kuroda A, Muto T, Esaki Y. Analysis of small cystic lesions of the pancreas. Int J Pancreato 1995;18:197-206  https://doi.org/10.1007/BF02784942
  4. Laffan TA, Horton KM, Klein AP, Berlanstein B, Siegelman SS, Kawamoto S, et al. Prevalence of unsuspected pancreatic cysts on MDCT. AJR Am J Roentgenol 2008;191:802-807  https://doi.org/10.2214/AJR.07.3340
  5. de Jong K, van Hooft JE, Nio CY, Gouma DJ, Dijkgraaf MG, Bruno MJ, et al. Accuracy of preoperative workup in a prospective series of surgically resected cystic pancreatic lesions. Scand J Gastroenterol 2012;47:1056-1063  https://doi.org/10.3109/00365521.2012.674970
  6. de Jong K, Nio CY, Hermans JJ, Dijkgraaf MG, Gouma DJ, Van Eijck CH, et al. High prevalence of pancreatic cysts detected by screening magnetic resonance imaging examinations. Clin Gastroenterol Hepatol 2010;8:806-811  https://doi.org/10.1016/j.cgh.2010.05.017
  7. Mella JM, Gomez EJ, Omodeo M, Manzotti M, Roel M, Pereyra L, et al. Prevalence of incidental clinically relevant pancreatic cysts at diagnosis based on current guidelines. Gastroenterol Hepatol (English Edition) 2018;41:293-301  https://doi.org/10.1016/j.gastre.2018.05.016
  8. Megibow AJ, Baker ME, Morgan DE, Kamel IR, Sahani DV, Newman E, et al. Management of incidental pancreatic cysts: a white paper of the ACR incidental findings committee. J Am Coll Radiol 2017;14:911-923  https://doi.org/10.1016/j.jacr.2017.03.010
  9. Vege SS, Ziring B, Jain R, Moayyedi P, Adams MA, Dorn SD, et al. American gastroenterological association institute guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts. Gastroenterology 2015;148:819-822  https://doi.org/10.1053/j.gastro.2015.01.015
  10. Tanaka M, Fernandez-del Castillo C, Kamisawa T, Jang JY, Levy P, Ohtsuka T, et al. Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology 2017;17:738-753  https://doi.org/10.1016/j.pan.2017.07.007
  11. Tanaka M, Fernandez-del Castillo C, Adsay V, Chari S, Falconi M, Jang JY, et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 2012;12:183-197  https://doi.org/10.1016/j.pan.2012.04.004
  12. Tanaka M, Chari S, Adsay V, Fernandez-del Castillo C, Falconi M, Shimizu M, et al; International Association of Pancreatology. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 2006;6:17-32  https://doi.org/10.1159/000090023
  13. American Gastroenterological Association. AGA Section. Managing pancreatic cysts: a patient guide. Gastroenterology 2015;149:498-499  https://doi.org/10.1053/j.gastro.2015.06.042
  14. Del Chiaro M, Verbeke C, Salvia R, Kloppel G, Werner J, McKay C, et al. European experts consensus statement on cystic tumours of the pancreas. Dig Liver Dis 2013;45:703-711  https://doi.org/10.1016/j.dld.2013.01.010
  15. Italian Association of Hospital Gastroenterologists and Endoscopists; Italian Association for the Study of the Pancreas, Buscarini E, Pezzilli R, Cannizzaro R, De Angelis C, et al. Italian consensus guidelines for the diagnostic work-up and follow-up of cystic pancreatic neoplasms. Dig Liver Dis 2014;46:479-493  https://doi.org/10.1016/j.dld.2013.12.019
  16. European Study Group on Cystic Tumours of the Pancreas. European evidence-based guidelines on pancreatic cystic neoplasms. Gut 2018;67:789-804  https://doi.org/10.1136/gutjnl-2018-316027
  17. Berland LL, Silverman SG, Gore RM, Mayo-Smith WW, Megibow AJ, Yee J, et al. Managing incidental findings on abdominal CT: white paper of the ACR incidental findings committee. J Am Coll Radiol 2010;7:754-773  https://doi.org/10.1016/j.jacr.2010.06.013
  18. Kang MJ, Jang JY, Kim SJ, Lee KB, Ryu JK, Kim YT, et al. Cyst growth rate predicts malignancy in patients with branch duct intraductal papillary mucinous neoplasms. Clin Gastroenterol Hepatol 2011;9:87-93  https://doi.org/10.1016/j.cgh.2010.09.008
  19. Kwong WT, Lawson RD, Hunt G, Fehmi SM, Proudfoot JA, Xu R, et al. Rapid growth rates of suspected pancreatic cyst branch duct intraductal papillary mucinous neoplasms predict malignancy. Dig Dis Sci 2015;60:2800-2806  https://doi.org/10.1007/s10620-015-3679-8
  20. Kim SH, Lee JM, Lee ES, Baek JH, Kim JH, Han JK, et al. Intraductal papillary mucinous neoplasms of the pancreas: evaluation of malignant potential and surgical resectability by using MR imaging with MR cholangiography. Radiology 2014;274:723-733  https://doi.org/10.1148/radiol.14132960
  21. Choi SY, Kim JH, Yu MH, Eun HW, Lee HK, Han JK. Diagnostic performance and imaging features for predicting the malignant potential of intraductal papillary mucinous neoplasm of the pancreas: a comparison of EUS, contrast-enhanced CT and MRI. Abdom Radiol (NY) 2017;42:1449-1458  https://doi.org/10.1007/s00261-017-1053-3
  22. Boos J, Brook A, Chingkoe CM, Morrison T, Mortele K, Raptopoulos V, et al. MDCT vs. MRI for incidental pancreatic cysts: measurement variability and impact on clinical management. Abdom Radiol (NY) 2017;42:521-530  https://doi.org/10.1007/s00261-016-0883-8
  23. Gazelle GS, Mueller PR, Raafat N, Halpern EF, Cardenosa G, Warshaw AL. Cystic neoplasms of the pancreas: evaluation with endoscopic retrograde pancreatography. Radiology 1993;188:633-636  https://doi.org/10.1148/radiology.188.3.8394590
  24. Koito K, Namieno T, Ichimura T, Yama N, Hareyama M, Morita K, et al. Mucin-producing pancreatic tumors: comparison of MR cholangiopancreatography with endoscopic retrograde cholangiopancreatography. Radiology 1998;208:231-237  https://doi.org/10.1148/radiology.208.1.9646818
  25. Nordback I, Auvinen O, Airo I, Isolauri J, Teerenhovi O. ERCP in evaluating the mode of therapy in pancreatic pseudocyst. HPB Surg 1988;1:35-44  https://doi.org/10.1155/1988/47060
  26. Kim JH, Eun HW, Park HJ, Hong SS, Kim YJ. Diagnostic performance of MRI and EUS in the differentiation of benign from malignant pancreatic cyst and cyst communication with the main duct. Eur J Radiol 2012;81:2927-2935  https://doi.org/10.1016/j.ejrad.2011.12.019
  27. Kim YC, Choi JY, Chung YE, Bang S, Kim MJ, Park MS, et al. Comparison of MRI and endoscopic ultrasound in the characterization of pancreatic cystic lesions. AJR Am J Roentgenol 2010;195:947-952  https://doi.org/10.2214/AJR.09.3985
  28. Waters JA, Schmidt CM, Pinchot JW, White PB, Cummings OW, Pitt HA, et al. CT vs MRCP: optimal classification of IPMN type and extent. J Gastrointest Surg 2008;12:101-109  https://doi.org/10.1007/s11605-007-0367-9
  29. Song SJ, Lee JM, Kim YJ, Kim SH, Lee JY, Han JK, et al. Differentiation of intraductal papillary mucinous neoplasms from other pancreatic cystic masses: comparison of multirow-detector CT and MR imaging using ROC analysis. JJ Magn Reson Imaging 2007;26:86-93  https://doi.org/10.1002/jmri.21001
  30. Matthaei H, Norris AL, Tsiatis AC, Olino K, Hong SM, dal Molin M, et al. Clinicopathological characteristics and molecular analyses of multifocal intraductal papillary mucinous neoplasms of the pancreas. Ann Surg 2012;255:326-333  https://doi.org/10.1097/SLA.0b013e3182378a18
  31. Rosenblatt R, Dorfman V, Epelboym I, Poneros JM, Sethi A, Lightdale C, et al. Demographic features and natural history of intermediate-risk multifocal versus unifocal intraductal papillary mucinous neoplasms. Pancreas 2015;44:478-483  https://doi.org/10.1097/MPA.0000000000000264
  32. Schmidt CM, White PB, Waters JA, Yiannoutsos CT, Cummings OW, Baker M, et al. Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology. Ann Surg 2007;246:644-651; discussion 651-654  https://doi.org/10.1097/SLA.0b013e318155a9e5
  33. Mori Y, Ohtsuka T, Kono H, Ideno N, Aso T, Nagayoshi Y, et al. Management strategy for multifocal branch duct intraductal papillary mucinous neoplasms of the pancreas. Pancreas 2012;41:1008-1012  https://doi.org/10.1097/MPA.0b013e31824b22c6
  34. Arikawa S, Uchida M, Uozumi J, Sakoda J, Kaida H, Kunou Y, et al. Utility of multidetector row CT in diagnosing branch duct IPMNs of the pancreas compared with MR cholangiopancreatography and endoscopic ultrasonography. Kurume Med J 2010;57:91-100  https://doi.org/10.2739/kurumemedj.57.91
  35. Correa-Gallego C, Do R, LaFemina J, Gonen M, D'Angelica MI, DeMatteo RP, et al. Predicting dysplasia and invasive carcinoma in intraductal papillary mucinous neoplasms of the pancreas: development of a preoperative nomogram. Ann Surg Oncol 2013;20:4348-4355  https://doi.org/10.1245/s10434-013-3207-z
  36. Crippa S, Salvia R, Warshaw AL, Dominguez I, Bassi C, Falconi M, et al. Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients. Ann Surg 2008;247:571-579  https://doi.org/10.1097/SLA.0b013e31811f4449
  37. Kang HJ, Lee JM, Joo I, Hur BY, Jeon JH, Jang JY, et al. Assessment of malignant potential in intraductal papillary mucinous neoplasms of the pancreas: comparison between multidetector CT and MR imaging with MR cholangiopancreatography. Radiology 2015;279:128-139  https://doi.org/10.1148/radiol.2015150217
  38. Kim TH, Song TJ, Hwang JH, Yoo KS, Lee WJ, Lee KH, et al. Predictors of malignancy in pure branch duct type intraductal papillary mucinous neoplasm of the pancreas: a nationwide multicenter study. Pancreatology 2015;15:405-410  https://doi.org/10.1016/j.pan.2015.04.010
  39. Kirkpatrick ID, Desser TS, Nino-Murcia M, Jeffrey RB. Small cystic lesions of the pancreas: clinical significance and findings at follow-up. Abdom Imaging 2007;32:119-125  https://doi.org/10.1007/s00261-006-9080-5
  40. Manfredi R, Graziani R, Motton M, Mantovani W, Baltieri S, Tognolini A, et al. Main pancreatic duct intraductal papillary mucinous neoplasms: accuracy of MR imaging in differentiation between benign and malignant tumors compared with histopathologic analysis. Radiology 2009;253:106-115  https://doi.org/10.1148/radiol.2531080604
  41. Pilleul F, Rochette A, Partensky C, Scoazec JY, Bernard P, Valette PJ. Preoperative evaluation of intraductal papillary mucinous tumors performed by pancreatic magnetic resonance imaging and correlated with surgical and histopathologic findings. J Magn Reson Imaging 2005;21:237-244  https://doi.org/10.1002/jmri.20254
  42. Uehara H, Ishikawa O, Katayama K, Kawada N, Ikezawa K, Fukutake N, et al. Size of mural nodule as an indicator of surgery for branch duct intraductal papillary mucinous neoplasm of the pancreas during follow-up. J Gastroenterol 2011;46:657-663  https://doi.org/10.1007/s00535-010-0343-0
  43. Harima H, Kaino S, Shinoda S, Kawano M, Suenaga S, Sakaida I. Differential diagnosis of benign and malignant branch duct intraductal papillary mucinous neoplasm using contrast-enhanced endoscopic ultrasonography. World J Gastroenterol 2015;21:6252-6260  https://doi.org/10.3748/wjg.v21.i20.6252
  44. Castellano-Megias VM, Andres CI, Lopez-Alonso G, Colina-Ruizdelgado F. Pathological features and diagnosis of intraductal papillary mucinous neoplasm of the pancreas. World J Gastrointest Oncol 2014;6:311-324  https://doi.org/10.4251/wjgo.v6.i9.311
  45. Furukawa T, Kloppel G, Volkan Adsay N, Albores-Saavedra J, Fukushima N, Horii A, et al. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch 2005;447:794-799  https://doi.org/10.1007/s00428-005-0039-7
  46. Kim KW, Park SH, Pyo J, Yoon SH, Byun JH, Lee MG, et al. Imaging features to distinguish malignant and benign branch-duct type intraductal papillary mucinous neoplasms of the pancreas: a meta-analysis. Ann Surg 2014;259:72-81  https://doi.org/10.1097/SLA.0b013e31829385f7
  47. Salvia R, Fernandez-del Castillo C, Bassi C, Thayer SP, Falconi M, Mantovani W, et al. Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg 2004;239:678-685; discussion 685-687  https://doi.org/10.1097/01.sla.0000124386.54496.15
  48. Anand N, Sampath K, Wu BU. Cyst features and risk of malignancy in intraductal papillary mucinous neoplasms of the pancreas: a meta-analysis. Clin Gastroenterol Hepatol 2013;11:913-921  https://doi.org/10.1016/j.cgh.2013.02.010
  49. Procacci C, Megibow AJ, Carbognin G, Guarise A, Spoto E, Biasiutti C, et al. Intraductal papillary mucinous tumor of the pancreas: a pictorial essay. Radiographics 1999;19:1447-1463  https://doi.org/10.1148/radiographics.19.6.g99no011447
  50. Bournet B, Kirzin S, Carrere N, Portier G, Otal P, Selves J, et al. Clinical fate of branch duct and mixed forms of intraductal papillary mucinous neoplasia of the pancreas. J Gastroenterol Hepatol 2009;24:1211-1217  https://doi.org/10.1111/j.1440-1746.2009.05826.x
  51. Hackert T, Fritz S, Klauss M, Bergmann F, Hinz U, Strobel O, et al. Main-duct intraductal papillary mucinous neoplasm: high cancer risk in duct diameter of 5 to 9 mm. Ann Surg 2015;262:875-881; discussion 880-881 
  52. Kang MJ, Jang JY, Lee S, Park T, Lee SY, Kim SW. Clinicopathological meaning of size of main-duct dilatation in intraductal papillary mucinous neoplasm of pancreas: proposal of a simplified morphological classification based on the investigation on the size of main pancreatic duct. World J Surg 2015;39:2006-2013  https://doi.org/10.1007/s00268-015-3062-0
  53. Levy P, Jouannaud V, O'Toole D, Couvelard A, Vullierme MP, Palazzo L, et al. Natural history of intraductal papillary mucinous tumors of the pancreas: actuarial risk of malignancy. Clin Gastroenterol Hepatol 2006;4:460-468  https://doi.org/10.1016/j.cgh.2006.01.018
  54. Mimura T, Masuda A, Matsumoto I, Shiomi H, Yoshida S, Sugimoto M, et al. Predictors of malignant intraductal papillary mucinous neoplasm of the pancreas. J Clin Gastroenterol 2010;44:e224-e229  https://doi.org/10.1097/MCG.0b013e3181d8fb91
  55. Nara S, Onaya H, Hiraoka N, Shimada K, Sano T, Sakamoto Y, et al. Preoperative evaluation of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas: clinical, radiological, and pathological analysis of 123 cases. Pancreas 2009;38:8-16  https://doi.org/10.1097/MPA.0b013e318181b90d
  56. Serikawa M, Sasaki T, Fujimoto Y, Kuwahara K, Chayama K. Management of intraductal papillary-mucinous neoplasm of the pancreas: treatment strategy based on morphologic classification. J Clin Gastroenterol 2006;40:856-862  https://doi.org/10.1097/01.mcg.0000225609.63975.6f
  57. Shimizu Y, Yamaue H, Maguchi H, Yamao K, Hirono S, Osanai M, et al. Predictors of malignancy in intraductal papillary mucinous neoplasm of the pancreas: analysis of 310 pancreatic resection patients at multiple high-volume centers. Pancreas 2013;42:883-888  https://doi.org/10.1097/MPA.0b013e31827a7b84
  58. Waters JA, Schmidt CM. Intraductal papillary mucinous neoplasm-when to resect? Adv Surg 2008;42:87-108  https://doi.org/10.1016/j.yasu.2008.03.011
  59. Barron M, Roch A, Waters J, Parikh J, DeWitt J, Al-Haddad M, et al. Does preoperative cross-sectional imaging accurately predict main duct involvement in intraductal papillary mucinous neoplasm? J Gastrointest Surg 2014;18:447-456; discussion 5455-5456  https://doi.org/10.1007/s11605-013-2444-6
  60. Correa-Gallego C, Ferrone CR, Thayer SP, Wargo JA, Warshaw AL, Fernandez-del Castillo C. Incidental pancreatic cysts: do we really know what we are watching? Pancreatology 2010;10:144-150  https://doi.org/10.1159/000243733
  61. Ferrone CR, Correa-Gallego C, Warshaw AL, Brugge WR, Forcione DG, Thayer SP, et al. Current trends in pancreatic cystic neoplasms. Arch Surg 2009;144:448-454  https://doi.org/10.1001/archsurg.2009.36
  62. Seo N, Byun JH, Kim JH, Kim HJ, Lee SS, Song KB, et al. Validation of the 2012 international consensus guidelines using computed tomography and magnetic resonance imaging: branch duct and main duct intraductal papillary mucinous neoplasms of the pancreas. Ann Surg 2016;263:557-564  https://doi.org/10.1097/SLA.0000000000001217
  63. Sainani NI, Saokar A, Deshpande V, Fernandez-del Castillo C, Hahn P, Sahani DV. Comparative performance of MDCT and MRI with MR cholangiopancreatography in characterizing small pancreatic cysts. AJR Am J Roentgenol 2009;193:722-731  https://doi.org/10.2214/AJR.08.1253
  64. Walter TC, Steffen IG, Stelter LH, Maurer MH, Bahra M, Faber W, et al. Implications of imaging criteria for the management and treatment of intraductal papillary mucinous neoplasms-benign versus malignant findings. Eur Radiol 2015;25:1329-1338  https://doi.org/10.1007/s00330-014-3520-3
  65. Irie H, Yoshimitsu K, Aibe H, Tajima T, Nishie A, Nakayama T, et al. Natural history of pancreatic intraductal papillary mucinous tumor of branch duct type: follow-up study by magnetic resonance cholangiopancreatography. J Comput Assist Tomogr 2004;28:117-122  https://doi.org/10.1097/00004728-200401000-00020
  66. Sahani DV, Kadavigere R, Blake M, Fernandez-del Castillo C, Lauwers GY, Hahn PF. Intraductal papillary mucinous neoplasm of pancreas: multi-detector row CT with 2D curved reformations- -correlation with MRCP. Radiology 2006;238:560-569  https://doi.org/10.1148/radiol.2382041463
  67. Macari M, Lee T, Kim S, Jacobs S, Megibow AJ, Hajdu C, et al. Is gadolinium necessary for MRI follow-up evaluation of cystic lesions in the pancreas? Preliminary results. AJR Am J Roentgenol 2009;192:159-164  https://doi.org/10.2214/AJR.08.1068
  68. Nougaret S, Reinhold C, Chong J, Escal L, Mercier G, Fabre JM, et al. Incidental pancreatic cysts: natural history and diagnostic accuracy of a limited serial pancreatic cyst MRI protocol. Eur Radiol 2014;24:1020-1029  https://doi.org/10.1007/s00330-014-3112-2
  69. Pozzi-Mucelli RM, Rinta-Kiikka I, Wunsche K, Laukkarinen J, Labori KJ, Anonsen K, et al. Pancreatic MRI for the surveillance of cystic neoplasms: comparison of a short with a comprehensive imaging protocol. Eur Radiol 2017;27:41-50  https://doi.org/10.1007/s00330-016-4377-4
  70. Bae SY, Lee KT, Lee JH, Lee JK, Lee KH, Rhee JC. Proper management and follow-up strategy of branch duct intraductal papillary mucinous neoplasms of the pancreas. Dig Liver Dis 2012;44:257-260  https://doi.org/10.1016/j.dld.2011.09.010
  71. Crippa S, Pezzilli R, Bissolati M, Capurso G, Romano L, Brunori MP, et al. Active surveillance beyond 5 years is required for presumed branch-duct intraductal papillary mucinous neoplasms undergoing non-operative management. Am J Gastroenterol 2017;112:1153-1161  https://doi.org/10.1038/ajg.2017.43
  72. Choi SH, Park SH, Kim KW, Lee JY, Lee SS. Progression of unresected intraductal papillary mucinous neoplasms of the pancreas to cancer: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2017;15:1509-1520.e4  https://doi.org/10.1016/j.cgh.2017.03.020
  73. Brook OR, Beddy P, Pahade J, Couto C, Brennan I, Patel P, et al. Delayed growth in incidental pancreatic cysts: are the Current American College of Radiology recommendations for follow-up appropriate? Radiology 2015;278:752-761  https://doi.org/10.1148/radiol.2015140972
  74. Kayal M, Luk L, Hecht EM, Do C, Schrope BA, Chabot JA, et al. Long-term surveillance and timeline of progression of presumed low-risk intraductal papillary mucinous neoplasms. AJR Am J Roentgenol 2017;209:320-326  https://doi.org/10.2214/AJR.16.17249
  75. Tanno S, Nakano Y, Nishikawa T, Nakamura K, Sasajima J, Minoguchi M, et al. Natural history of branch duct intraductal papillary-mucinous neoplasms of the pancreas without mural nodules: long-term follow-up results. Gut 2008;57:339-343  https://doi.org/10.1136/gut.2007.129684
  76. Sawai Y, Yamao K, Bhatia V, Chiba T, Mizuno N, Sawaki A, et al. Development of pancreatic cancers during long-term follow-up of side-branch intraductal papillary mucinous neoplasms. Endoscopy 2010;42:1077-1084  https://doi.org/10.1055/s-0030-1255971
  77. Matsubara S, Tada M, Akahane M, Yagioka H, Kogure H, Sasaki T, et al. Incidental pancreatic cysts found by magnetic resonance imaging and their relationship with pancreatic cancer. Pancreas 2012;41:1241-1246  https://doi.org/10.1097/MPA.0b013e31824f5970
  78. Tada M, Kawabe T, Arizumi M, Togawa O, Matsubara S, Yamamoto N, et al. Pancreatic cancer in patients with pancreatic cystic lesions: a prospective study in 197 patients. Clin Gastroenterol Hepatol 2006;4:1265-1270  https://doi.org/10.1016/j.cgh.2006.07.013
  79. Yogi T, Hijioka S, Imaoka H, Mizuno N, Hara K, Tajika M, et al. Risk factors for postoperative recurrence of intraductal papillary mucinous neoplasms of the pancreas based on a long-term follow-up study: proposals for follow-up strategies. J Hepatobiliary Pancreat Sci 2015;22:757-765  https://doi.org/10.1002/jhbp.280
  80. Winter JM, Jiang W, Basturk O, Mino-Kenudson M, Fong ZV, Tan WP, et al. Recurrence and survival after resection of small intraductal papillary mucinous neoplasm-associated carcinomas (≤ 20-mm invasive component): a multi-institutional analysis. Ann Surg 2016;263:793-801  https://doi.org/10.1097/SLA.0000000000001319
  81. Tamura K, Ohtsuka T, Ideno N, Aso T, Shindo K, Aishima S, et al. Treatment strategy for main duct intraductal papillary mucinous neoplasms of the pancreas based on the assessment of recurrence in the remnant pancreas after resection: a retrospective review. Ann Surg 2014;259:360-368  https://doi.org/10.1097/SLA.0b013e3182a690ff
  82. Passot G, Lebeau R, Hervieu V, Ponchon T, Pilleul F, Adham M. Recurrences after surgical resection of intraductal papillary mucinous neoplasm of the pancreas: a single-center study of recurrence predictive factors. Pancreas 2012;41:137-141  https://doi.org/10.1097/MPA.0b013e318222bc9c
  83. Park J, Lee KT, Jang TH, Seo YW, Lee KH, Lee JK, et al. Risk factors associated with the postoperative recurrence of intraductal papillary mucinous neoplasms of the pancreas. Pancreas 2011;40:46-51  https://doi.org/10.1097/MPA.0b013e3181f66b74
  84. Fujii T, Kato K, Kodera Y, Kanda M, Nagai S, Yamada S, et al. Prognostic impact of pancreatic margin status in the intraductal papillary mucinous neoplasms of the pancreas. Surgery 2010;148:285-290 https://doi.org/10.1016/j.surg.2010.03.013